Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy

Clinical Oncology

Volumn 17, Issue 7, 2005, Pages 560-571

  Khoo, Vincent S ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Complications; Conformal; Dose escalation; Hypofractionation; Image guided radiotherapy; Intensity modulation; Outcomes; Prostate cancer; Radiotherapy

Indexed keywords

IODINE 125; PALLADIUM 103; PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; GASTROINTESTINAL TOXICITY; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE IRRADIATION; MALE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROCTITIS; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADIATION HAZARD; RADIATION RESPONSE; RECTUM DISEASE; RELIABILITY; RISK FACTOR; SAFETY; TREATMENT OUTCOME; TREATMENT PLANNING;

BRACHYTHERAPY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 25144472058     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2005.07.006     Document Type: Article

References (75)

1. http://www.cancerresearchuk.org/aboutcancer/specificcancers/ prostatecancer (last accessed 19 July, 2005)
2. M.V. Pilepich J.M. Krall W.T. Sause et al. Prognostic factors in carcinoma of the prostate - analysis of RTOG study 75-06 Int J Radiat Oncol Biol Phys 13 1987 339-349
3. G.K. Zagars A.C. von-Eschenbach D.E. Johnson M.J. Oswald Stage C adenocarcinoma of the prostate. An analysis of 551 patients treated with external beam radiation Cancer 60 1987 1489-1499
4. C.A. Perez M.V. Pilepich D. Garcia J.R. Simpson F. Zivnuska M.A. Hederman Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: Experience at the Mallinckrodt Institute of Radiology Natl Cancer Inst Monogr 1988 85-94
5. D.R. Goffinet M.A. Bagshaw Radiation therapy of prostate carcinoma: thirty year experience at Stanford University In: F.H. Schroder ed. EORTC genitounrinary group monograph 8: Treatment of prostate cancer - facts and controversies 1990 Wiley-Liss Inc New York, Chichester, Brisbane, Toronto, Singapore 209-222
6. G.E. Hanks S.A. Leibel J.M. Krall S. Kramer Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate Int J Radiat Oncol Biol Phys 11 1985 153-157
7. C.A. Perez B.J. Walz F.R. Zivnuska Irradiation of carcinoma of the prostate localized to the pelvis: Analysis of tumor response and prognosis Int J Radiat Oncol Biol Phys 6 1980 555-563
8. G.E. Hanks K.L. Martz J.J. Diamond The effect of dose on local control of prostate cancer Int J Radiat Oncol Biol Phys 15 1988 1299-1305
9. A. Pollack L.G. Smith A.C. von Eschenbach External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era Int J Radiat Oncol Biol Phys 48 2000 507-512
10. R. Valicenti J. Lu M. Pilepich S. Asbell D. Grignon Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials J Clin Oncol 18 2000 2740-2746
11. G.E. Hanks J.M. Krall K.L. Martz J.J. Diamond S. Kramer The outcome of 313 patients with T1 (UICC) prostate cancer treated with external beam irradiation Int J Radiat Oncol Biol Phys 14 1988 243-248
12. M.V. Pilepich S.O. Asbell J.M. Krall et al. Correlation of radiotherapeutic parameters and treatment related morbidity-analysis of RTOG Study 77-06 Int J Radiat Oncol Biol Phys 13 1987 1007-1012
13. C.A. Lawton M. Won M.V. Pilepich et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706 Int J Radiat Oncol Biol Phys 21 1991 935-939
14. W.G.J.M. Smit P.A. Helle L.J. van-Putten A.J. Wijnmaalen J.J. Seldenrath B.H. van-der-Werf-Messing Late radiation damage in prostate cancer patients treated by high dose external beam radiotherapy in relation to rectal dose Int J Radiat Oncol Biol Phys 18 1990 23-29
15. T.D. Sterling K.C. Knowlton J.J. Weinkam D.M. Sterling Dynamic display of radiotherapy plans using computer-produced films Radiology 107 1973 689-691
16. L.E. Reinstein D. McShan B.M. Webber A.S. Glicksman A computer-assisted three-dimensional treatment planning system Radiology 127 1978 259-264
17. M. Goitein J. Wittenberg M. Mendiondo et al. The value of CT scanning in radiation therapy treatment planning: A prospective study Int J Radiat Oncol Biol Phys 5 1979 1787-1798
18. R.E. Drzymala R. Mohan L. Brewster et al. Dose-volume histograms Int J Radiat Oncol Biol Phys 21 1991 71-78
19. A.B. Wolbarst L.M. Chin G.K. Svensson Optimization of radiation therapy: integral-response of a model biological system Int J Radiat Oncol Biol Phys 8 1982 1761-1769
20. J.T. Lyman A.B. Wolbarst Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms Int J Radiat Oncol Biol Phys 13 1987 103-109
21. D.P. Dearnaley V.S. Khoo A.R. Norman et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial Lancet 353 1999 267-272
22. P.C. Koper J.C. Stroom W.L. van Putten et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: A randomized study Int J Radiat Oncol Biol Phys 43 1999 727-734
23. NICE National Institute for Clinical Excellence - guidance on cancer services: Improving outcomes in urological cancers The manual: NICE September 2002 MidCity Place, 71 High Holborn, London WC1V 6NA
24. J.B. Fiveash G. Hanks M. Roach et al. 3D conformal radiation therapy (3DCRT) for high grade prostate cancer: A multi-institutional review Int J Radiat Oncol Biol Phys 47 2000 335-342
25. P.A. Kupelian D.S. Mohan J. Lyons E.A. Klein C.A. Reddy Higher than standard radiation doses(> or = 72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer Int J Radiat Oncol Biol Phys 46 2000 567-574
26. J.A. Lyons P.A. Kupelian D.S. Mohan C.A. Reddy E.A. Klein Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate Urology 55 2000 85-90
27. M.J. Zelefsky S.A. Leibel P.B. Gaudin et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer Int J Radiat Oncol Biol Phys 41 1998 491-500
28. W.U. Shipley L.J. Verhey J.E. Munzenrider et al. Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone Int J Radiat Oncol Biol Phys 32 1995 3-12
29. B.G. Gardner A.L. Zietman W.U. Shipley U.E. Skowronski P. McManus Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer J Urol 167 2002 123-126
30. C.J. Rossi A.L. Zietman M. DeSilvio et al. A randomized trial comparing conventional dose (70.2 GyE) and high dose (79.2 GyE) conformal radiation in early stage adenocarcinoma of the prostate: An interim analysis of PROG 95-09 In: S.M. Grunberg editor. The 2005 multidisciplinary prostate cancer symposium program/proceedings, 2005 2005 American Society of Clinical Oncology (ASCO) Orlando, Florida 63
31. A. Pollack G.K. Zagars G. Starkschall et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097-1105
32. D.P. Dearnaley E. Hall D. Lawrence et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects Br J Cancer 92 2005 488-498
33. B. Seddon M. Bidmead J. Wilson V.S. Khoo D.P. Dearnaley Target volume definition in conformal radiotherapy for prostate cancer: Quality assurance in the MRC RT-01 trial Radiother Oncol 56 2000 73-83
34. M.R. Sydes R.J. Stephens A.R. Moore et al. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): Methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer Radiother Oncol 72 2004 199-211
35. J. Lebesque P. Koper A. Slot H. Tabak W. Heemsbergen W.V. Putten Acute and late GI and GU toxicity after prostate irradiation to doses of 68 Gy and 78 Gy: Results of a randomized trial Int J Radiat Oncol Biol Phys 57 2003 S152
36. V. Beckendorf J.M. Bachaud P. Bey et al. Target-volume and critical-organ delineation for conformal radiotherapy of prostate cancer: Experience of French dose-escalation trials Cancer Radiother 6 Suppl 1 2002 78s-92s
37. S. Webb Intensity modulated radiotherapy 2000 Institute of Physics Publishing Bristol, UK
38. M.J. Zelefsky Z. Fuks L. Happersett et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer Radiother Oncol 55 2000 241-249
39. M.J. Zelefsky Z. Fuks M. Hunt et al. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients Int J Radiat Oncol Biol Phys 53 2002 1111-1116
40. M.J. Zelefsky Z. Fuks M. Hunt et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J Urol 166 2001 876-881
41. M. Roach M. DeSilvio C.R. Thomas Jr. et al. Field size and progression free survival (PFS) after neoadjuvant hormonal therapy (HT) and radiotherapy (RT) for prostate cancer: Secondary analysis of RTOG 9413 In: S.M. Grunberg editor. The 2005 multidisciplinary prostate cancer symposium program/proceedings, 2005 2005 American Society of Clinical Oncology (ASCO) Orlando, Florida 77
42. C.M. Nutting D.J. Convery V.P. Cosgrove et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer Int J Radiat Oncol Biol Phys 48 2000 649-656
43. M.T. Guerrero-Urbano A. Norman E. Adams et al. A phase 1 dose escalation study of intensity modulated radiotherapy (IMRT) to treat the prostate and pelvic nodes in patients with locally advanced prostate cancer In: S.M. Grunberg editor. The 2005 multidisciplinary prostate cancer symposium program/proceedings, 2005 2005 American Society of Clinical Oncology (ASCO) Orlando, Florida 123
44. J.C. Blasko K. Wallner P.D. Grimm H. Ragde Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma J Urol 154 1995 1096-1099
45. K. Hu K. Wallner Clinical course of rectal bleeding following I-125 prostate brachytherapy Int J Radiat Oncol Biol Phys 41 1998 263-265
46. D.Y. Gelblum L. Potters Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer Int J Radiat Oncol Biol Phys 48 2000 119-124
47. G.S. Merrick W.M. Butler A.T. Dorsey R.W. Galbreath H. Blatt J.H. Lief Rectal function following prostate brachytherapy Int J Radiat Oncol Biol Phys 48 2000 667-674
48. K.M. Snyder R.G. Stock S.M. Hong Y.C. Lo N.N. Stone Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis Int J Radiat Oncol Biol Phys 50 2001 335-341
49. H. Ragde G.L. Grado B.S. Nadir Brachytherapy for clinically localized prostate cancer: Thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Arch Esp Urol 54 2001 739-747
50. P.D. Grimm J.C. Blasko J.E. Sylvester R.M. Meier W. Cavanagh 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy Int J Radiat Oncol Biol Phys 51 2001 31-40
51. J.E. Sylvester J.C. Blasko P.D. Grimm R. Meier J.A. Malmgren Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: The Seattle experience Int J Radiat Oncol Biol Phys 57 2003 944-952
52. R.R. Rodriguez D.J. Demanes G.A. Altieri High dose rate brachytherapy in the treatment of prostate cancer Hematol Oncol Clin North Am 13 1999 503-523
53. F.A. Vicini C. Vargas G. Edmundson L. Kestin A. Martinez The role of high-dose rate brachytherapy in locally advanced prostate cancer Semin Radiat Oncol 13 2003 98-108
54. L.L. Kestin N.S. Goldstein F.A. Vicini et al. Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy Int J Radiat Oncol Biol Phys 54 2002 107-118
55. D.J. Brenner E.J. Hall Fractionation and protraction for radiotherapy of prostate carcinoma Int J Radiat Oncol Biol Phys 43 1999 1095-1101
56. J. Fowler R. Chappell M. Ritter Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 50 2001 1021-1031
57. E.E. Yeoh R.J. Fraser R.E. McGowan et al. Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: Early results of a phase III randomized trial Int J Radiat Oncol Biol Phys 55 2003 943-955
58. J.E. Livsey R.A. Cowan J.P. Wylie et al. Hypofractionated conformal radiotherapy in carcinoma of the prostate: Five-year outcome analysis Int J Radiat Oncol Biol Phys 57 2003 1254-1259
59. V. Khoo A. Norman I. Syndikus et al. Randomized pilot study of conventional or hypofractionated high dose intensity modulated prostate radiotherapy (CHHIP)-acute toxicity report In: S.M. Grunberg editor. The 2005 multidisciplinary prostate cancer symposium program/proceedings, 2005 2005 American Society of Clinical Oncology (ASCO) Orlando, Florida 78
60. A.E. Nahum B. Movsas E.M. Horwitz C.C. Stobbe J.D. Chapman Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the alpha/beta ratio Int J Radiat Oncol Biol Phys 57 2003 391-401
61. A.R. Padhani V.S. Khoo J. Suckling J.E. Husband M.O. Leach D.P. Dearnaley Evaluating the effect of rectal distension and movement on prostate gland position using cine MRI Int J Radiat Oncol Biol Phys 44 1999 525-533
62. R.K. Ten-Haken J.D. Forman D.K. Heimburger et al. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder Int J Radiat Oncol Biol Phys 20 1991 1317-1324
63. M. van Herk A. Bruce A.P. Kroes T. Shouman A. Touw J.V. Lebesque Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration Int J Radiat Oncol Biol Phys 33 1995 1311-1320
64. L.A. Dawson K. Mah E. Franssen G. Morton Target postion variability throughout prostate radiotherapy Int J Radiat Oncol Biol Phys 42 1998 1155-1161
65. M.J. Zelefsky D. Crean G.S. Mageras et al. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy Radiother Oncol 50 1999 225-234
66. V. Khoo Utilization of portal imaging in positional control Oncologia 27 2004 23-27
67. V.S. Khoo 4D radiotherapy: On-line imaging on the linear accelerator RAD J April 2005 29-30
68. S. Wachter N. Gerstner D. Dorner et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 52 2002 91-100
69. P. Bergstrom P.O. Lofroth A. Widmark High-precision conformal radiotherapy (HPCRT) of prostate cancer - a new technique for exact positioning of the prostate at the time of treatment Int J Radiat Oncol Biol Phys 42 1998 305-311
70. A.M. Henry C. Wilkinson J.P. Wylie J.P. Logue P. Price V.S. Khoo Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: An assessment of procedure related morbidity, patient acceptability and accuracy Radiother Oncol 73 2004 57-59
71. A.J. Nederveen H. Dehnad U.A. van der Heide R.J. van Moorselaar P. Hofman J.J. Lagendijk Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials Radiother Oncol 68 2003 81-88
72. D.A. Jaffray J.H. Siewerdsen J.W. Wong A.A. Martinez Flat-panel cone-beam computed tomography for image-guided radiation therapy Int J Radiat Oncol Biol Phys 53 2002 1337-1349
73. S. Shimizu H. Shirato K. Kitamura et al. Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers Int J Radiat Oncol Biol Phys 48 2000 1591-1597
74. C.R. King J. Lehmann J.R. Adler J. Hai CyberKnife radiotherapy for localized prostate cancer: Rationale and technical feasibility Technol Cancer Res Treat 2 2003 25-30
75. A.W. Beavis Is tomotherapy the future of IMRT? Br J Radiol 77 2004 285-295